Types of Cancer We Treat

Pancreatic Cancer

We combine evidence-based medicine with compassionate, personalized care to diagnose and treat people with pancreatic cancer. Our team of specialists is at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

Our experts create an individualized treatment plan for you, drawing on our expertise in endoscopic and surgical treatments as well as medical therapies. Learn more about our comprehensive care for pancreatic cancer at Perlmutter Cancer Center’s Pancreatic Cancer Center.

Find a Doctor & Schedule
Diagnosis
Surgery
Chemotherapy & Targeted Drugs
Radiation Therapy

Related News

Medical Oncologist Advances Pancreatic Cancer Treatments
Read Story
Innovative Pancreatic Cancer Clinical Trial Begins Enrolling
Read Story
Pancreatic Cancer Cells Use Recycling to Evade Immunotherapy
Read Story
To Stop a Deadly Cancer, Cut Off Its Food Supply
Read Story
Pancreatic Tumor Cells Release Key Immune Signal
Read Story
Study Reveals How Pancreatic Cells Avert Starvation
Read Story
Expert Discusses Early Detection of Pancreatic Cancer
Read Story
New Program Aims to Stop Pancreatic Cancer Before It Starts
Read Story
Fungi May Drive Pancreatic Cancer
Read Story
Fungal Invasion of Pancreas Creates Cancer Risk
Read Story
Early Detection Can Improve Survival for Pancreatic Cancer
Read Story
Gene Action Needed for Early Steps Toward Pancreatic Cancer
Read Story

Clinical Trials and Research Studies

Phase 6

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Subjects with Pancreatic Cancer Whose Disease Has Progressed or Recurred

Learn More

Phase -1

Precision Promise Platform Trial for Metastatic Pancreatic Cancer Precision PromiseSM

Learn More

Phase 1

A phase I open-label dose-escalation study to investigate the safety pharmacokinetics pharmacodynamics and clinical activity of GSK3368715 in participants with solid tumors and DLBCL

Learn More

Phase 3

A Phase 3 Randomized Double-Blind Study of Pamrevlumab or Placebo in combination with Gemcitabine Plus Nab-Paclitaxel as Neoadjuvant Treatment in Patients with Locally Advanced Unresectable Pancreatic Cancer

Learn More
View All Related Clinical Trials (11)